founding member @canalecomm; prez @NIRI San Diego; #biotech #agencylife #girldad
San Diego, CA
Joined August 2008
- Tweets1.5K
- Following517
- Followers484
- Likes898
Pinned Tweet
most of my work is behind the scenes. sometimes easier said than done. #photobomb #inadvertent #cnbc cnbc.com/2020/02/19/the-ultr…
Jason Spark retweeted
Ugh. Honey, I (new Alzheimer drugs) shrunk the brain
science.org/content/article/…
@ScienceMagazine @jcouzin
Jason Spark retweeted
Today, our CEO, Laura Shawver, Ph.D. (@lshawverO), will be participating in the @statnews #STATSummit 2021 panel entitled “Breaking Biotech’s Barriers” moderated by @sheridan_kate at 2:40 p.m. ET / 11:40 a.m. PT. Learn more and register here: bit.ly/3n0FrVP
“You know what the happiest animal on Earth is? It’s a goldfish. You know why? Got a 10-second memory. Be a goldfish”
The launch of the new season just might push me into commuting to work again. #drivetime #podcast
regardless of where you land on this topic, issues management and crisis comms teams are put to an epic test here.
Breaking News: A third member of the FDA's expert panel has resigned in the wake of the controversial Alzheimer's drug approval, calling it the "worst drug approval decision in recent U.S. history"
endpts.com/harvards-aaron-ke…
The last time I mistakenly took that call, I asked the caller for their name and SS# to prove they were legit. They so craftily said that they were my father. Click
I was the Spark first. But not sure I have a claim in this fight. @AmberTongPW
Spark Therapeutics, which is now a subsidiary of Roche, has sued bluebird for trademark infringement — through a promotional campaign around its experimental treatment for sickle cell disease where the word “spark” features prominently.
endpts.com/be-the-spark-roch…
please don't dilute the Spark name. 😅@pharmalot
Spark Therapeutics claims that Bluebird Bio has “misappropriated and diluted” the Spark name. buff.ly/33Zmetu
Creative headlines today on the menin inhibitor news:
"Menin High Places" by @ORandyO @BioWorld
"Boyz II Men(in): Pass You By" by Jonathan Chang @SVBLeerink
Well played. 🎤💧
"Boyz II Men(in): Pass You By" is a follow up to "Doin' Just Fine" and "The Exclusive Interview" Boyz II Men(in) reports also by Jonathan Chang @SVBLeerink
Never skipped a beat... 🤯
Great use of digital, visual and written content to tell this story.
Great visualization of how aerosols move through an airplane. Air changes out every 2-3 minutes and passes through a HEPA filter that removes aerosols. Very important to minimize mask-off time. nytimes.com/interactive/2021…
When do we think they’ll open up vaccinations to 55+? This group is in limbo.
Public companies need to be comfortable building and tapping into a deep tool chest of communications tactics to reach investors. This goes beyond retail. More than just PRs, conference calls and PowerPoints. #investorrelations #IR #communications @NIRI_National @WSJ
The recent surge of small investors into some companies’ stocks is pushing investor relations departments to seek ways of engaging with their new shareholders, @Nina_Trentmann reports for @CFOJournal @WSJ. wsj.com/articles/companies-z…
Moms cousin finally discharged after 30 days in ICU with Covid. Learning to walk and talk on his own again. That’s one strong hombre. 💪 Can’t #vaccinate fast enough.
another great vaccine story from @helenbranswell. I often hear, I got "the moderna" but that's a perception concern as we move towards vaccinating a general population. statnews.com/2021/02/17/the-… via @statnews
Jason Spark retweeted
Agree with this
Right now, demand for vaccines >>> supply of vaccines
That will stay true for all of February and much of March
But by April, this will begin to change
And by May, supply > demand in US
By summer? supply >>> demand
Family and friends continuously ask me to help filter the news to help make sense of it. I thought today’s @nytimes morning newsletter by @DLeonhardt was outstanding, and I shared it with as many as I could. He said what needed to be said.
nytimes.com/2021/02/01/brief…
The Pharma industry can be fixated on efficacy endpoints as it should. There is rigor behind science.
But my parents are not concerned with efficacy rates of various #covid vaccines. They want to know what will keep them out of the hospital, what will prevent severe infections and death. The good news is there are now several options that do that. 👍💪